News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CHANG LINDA L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2018 |
4
| CHANG LINDA L (CFO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $8.95, valued at
$89.5k
|
|
| 02/28/2018 |
4
| CHANG LINDA L (CFO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $8.92, valued at
$178.4k
|
|
| 09/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/09/2015 |
4
| CHANG LINDA L (SVP, CFO & Secretary) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Sold 29,600 shares
@ $2.1, valued at
$62.2k
Exercised 29,600 options to buy
@ $1.13, valued at
$33.4k
|
|
| 12/10/2014 |
4
| CHANG LINDA L (SVP, CFO & Secretary) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Granted 186,207 options to buy
@ $1.71, valued at
$318.4k
|
|
| 01/31/2014 |
4
| CHANG LINDA L (SVP & CFO) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Granted 210,000 options to buy
@ $1.94, valued at
$407.4k
|
|
| 12/05/2012 |
4
| CHANG LINDA L (SVP & CFO) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
| 11/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2011 |
3
| CHANG LINDA L (SVP & CFO) has filed a Form 3 on PHARMATHENE, INC |
|
|